Meeting
2012 Genitourinary Cancers Symposium
Use of radiographic progression to predict overall survival in men with castration-refractory prostate cancer.
Authors
Kazumi Kamoi
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Kazumi Kamoi , Koji Okihara , Natsuki Takaha , Tsuyoshi Iwata , Akihiro Kawauchi , Tsuneharu Miki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 254)
DOI
10.1200/jco.2012.30.5_suppl.254
Abstract #
254
Poster Bd #
E6
Abstract Disclosures
Similar Posters
Poster
2012 Genitourinary Cancers Symposium
Skeletal events unrelated to bone metastasis in men with castration-refractory prostate cancer.
First Author: Kazumi Kamoi
Poster
2020 ASCO Virtual Scientific Program
Radiographic paradoxical response in patients with metastatic castrate-resistant prostate cancer (mCRPC) undergoing treatment with second-generation hormone therapy (second-HT).
First Author: Jamal Alamiri
Poster
2014 Genitourinary Cancers Symposium
Salvage chemotherapy with carboplatin plus weekly docetaxel in patients (pts) with castration- and docetaxel-resistant prostate cancer (DRPC): Associations of patient and disease characteristics with overall survival (OS).
First Author: Christoph W. Reuter
Poster
2013 Genitourinary Cancers Symposium
Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).
First Author: Christoph W. Reuter